Biovail Settles Cardizem Suit With Watson Unit
A Biovail Corp. subsidiary has agreed to grant generics manufacturer Andrx Pharmaceuticals LLC an exclusive patent license to manufacture Biovail's popular hypertension drug Cardizem in exchange for an undisclosed royalty, bringing...To view the full article, register now.
Already a subscriber? Click here to view full article